LANSING, Mich. — The McLaren Health Care Corp. in Lansing announced plans to build a new $450 million hospital in south Lansing. Plans also include the expansion of its academic partnership on health care with Michigan State University (MSU) in East Lansing. The project was announced Dec. 4, 2017.
McLaren hired the Kramer Management Group in Lansing for owner’s services. Pre-construction programing and planning is being provided by the design-build team of Michigan-based Barton Malow/Christman Joint Venture and CallisonRTKL based out of Baltimore, Md.
The new 240-bed hospital will replace the McLaren Greater Lansing and McLaren Orthopedic Hospital, which Grand Blanc-based McLaren acquired in 1997. The new hospital will occupy a 52-acre campus.
Other buildings will include an outpatient facility and the Karmanos Cancer Institute medical center. The hospital is expected to open in late 2021 and will feature a state-of-the-art hospital, cancer center, ambulatory care center and other facilities to support health care delivery, educational opportunities and medical research.
“This is truly a defining moment in McLaren’s growth as the leading statewide clinical and insurance enterprise,” said Phil Incarnati, chief executive officer at McLaren in a recent interview with Crain’s Detroit Business. “This is an extraordinary opportunity to collaborate with MSU to redesign and elevate health care for a region and the state for generations to come. Our partnership will transform health care delivery to support a world-class medical experience and advance pioneering medical research.”
An estimated 2,500 jobs will be created in the construction of the health care campus. An additional 80 employees will be hired when the new hospital opens, as well as the hiring of 75 current full- and part-time openings at the hospitals, which employ about 2,000 workers and staff.
The McLaren 12-hospital health system has 35 clinical trials with MSU, and has 425 residents and fellows at its hospitals statewide from MSU. “That will grow. We plan to do more cancer research with Karmanos (Cancer Institute) with precision medicine,” said Incarnati. “This adds another dimension to university research park. It will attract others, and we expect it to be an incubation site for research.”